Stem Cells vs Knee Replacement: How to Decide

"Avoid knee replacement surgery" is one of the most effective marketing lines in regenerative medicine, because it names something people genuinely fear. It also frames a comparison that is not quite real.

These two are not competing treatments for the same patient. They sit at different points in the disease, with very different evidence behind them.

Side by side

	Stem cell injection	Total knee replacement
What it is	Injection of cells into the joint	Surgical replacement of joint surfaces with implants
Evidence	Low certainty; most measured benefit placebo-attributable	Strong; decades of registry and trial data
FDA approved	No	Yes — devices and procedure are established
Typical cost	$5,000–$12,000 per knee	$30,000–$50,000
Insurance	No	Usually
Anaesthesia	Local	General or spinal
Recovery	Days; return to activity in weeks	6–12 weeks of rehab; up to a year for full recovery
Pain relief	Modest incremental effect over placebo	Substantial and reliable in appropriate candidates
Durability	Unclear; often described as 1–2 years	Most implants last 15–25 years
Reversible	Yes — changes nothing structurally	No
Serious risk	Low, but infection and other harms documented	Real: clot, infection, implant failure, ~1% serious complication

The honest framing

For mild to moderate arthritis, knee replacement is not on the table anyway. Surgeons will not replace a knee that is not badly damaged, because implants have a finite lifespan and a 55-year-old will likely need a revision. Here the real comparison is not injection versus surgery — it is injection versus exercise therapy, weight management, corticosteroid injection, and PRP, all of which cost less and several of which have better evidence.

For severe, bone-on-bone arthritis, injections are unlikely to help meaningfully. There is no evidence that stem cell treatment restores a joint at this stage. Here the comparison is real, and the evidence strongly favours replacement.

So the marketing promise — "avoid surgery" — is aimed hardest at the group for whom surgery was never the alternative.

What "avoiding surgery" actually means

An injection does not remove the option of replacement later. If it does not work, you have spent $10,000 and some months.

The genuine argument for delay is age. A replacement at 50 will likely need a revision, which is a harder operation with worse outcomes. Delaying to 60 or 65 is a real clinical goal — but it is normally pursued with weight management, activity modification, physical therapy and steroid injections, all of which are cheaper and better evidenced than cell therapy.

A reasonable sequence

1. Exercise therapy and weight management. First-line in every major guideline, and the most under-used effective treatment for knee osteoarthritis.
2. Corticosteroid injection. Cheap, covered, reliable short-term relief.
3. PRP or hyaluronic acid. Moderate evidence, moderate cost.
4. Stem cell injection. Optional, unproven, expensive — a reasonable choice for someone who understands that and can afford it without borrowing.
5. Replacement, when damage and symptoms justify it.

Get an opinion from someone who does not sell either

The most useful step is an assessment from an orthopaedic surgeon or rheumatologist with no financial interest in cell therapy. Ask them directly: how severe is the damage, am I a replacement candidate today, and what would you do?

Sources

1. Contextual effects of mesenchymal stem cell injections for knee osteoarthritis: systematic review and meta-analysis of RCTs. Frontiers in Medicine, 2025.
2. American Academy of Orthopaedic Surgeons — clinical practice guideline on management of osteoarthritis of the knee.
3. National registry data on total knee arthroplasty outcomes and implant survivorship.

---